Latest News and Press Releases
Want to stay updated on the latest news?
-
WEST LAFAYETTE, Ind., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Amplified Sciences, a clinical-stage life sciences diagnostic company that develops tests for early, more accurate detection of challenging...
-
Chemiluminescence Immunoassay Analyzers Market Size Worth USD 9.7 Billion in 2032 | Emergen Research
Vancouver, Dec. 18, 2023 (GLOBE NEWSWIRE) -- The global Chemiluminescence Immunoassay (CLIA) analyzers market size was USD 5.42 Billion in 2022 and is expected to register rapid revenue CAGR of 6.0%...
-
Pune, India, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Bovine tuberculosis (bTB) is a chronic infectious disease that primarily affects cattle, and is later transmitted to other animals and humans. The...
-
New York, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The global Clinical Immunoanalyzer Market is expected to witness significant growth at a remarkable CAGR of 5.0% during the forecast period of...
-
SAN FRANCISCO, U.S., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Chemiluminescence Immunoassay Analyzer Market By Product (Instruments,...
-
Pune, India, July 20, 2023 (GLOBE NEWSWIRE) -- According to Recently Published Report by The Insight Partners, “Immunodiagnostics Market Size Report and Forecast to 2030 - COVID-19 Impact and Global...
-
New York, NY, Jan. 25, 2023 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (the “Company”) (Nasdaq: ANPC), a biotechnology company with operations in the United States and China focused on...
-
New York, NY, Jan. 20, 2023 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (the “Company”) (Nasdaq: ANPC), a biotechnology company with operations in the United States and China focused on...
-
GARDEN CITY, NY, Oct. 18, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be...
-
GARDEN CITY, NY, Oct. 17, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth-oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly...